Table 2.
DV Internal concentration at plateaua (µM) |
|||
---|---|---|---|
Glucose* VPL^ |
+ − |
−# − |
+ + |
HB3 | 10.6 ± 1.0 | 8.20 ± 0.94 | 9.99 ± 0.46 |
Dd2 | 7.33 ± 0.72 | 10.8 ± 0.74 | 8.95 ± 0.5 |
C2GCO3 | 9.81 ± 0.56 | 8.26 ± 0.64 | 10.1 ± 0.76 |
C4Dd2 | 7.91 ± 0.56 | 10.8 ± 1.0 | 9.98 ± 0.73 |
Initial Rates (µmol L−1sec−1 × 10−2) |
|||
Glucose* VPL^ |
+ − |
−# − |
+ + |
HB3 | 4.24 ± 0.47 | 2.22 ± 0.35 | 4.94 ± 0.35 |
Dd2 | 2.61 ± 0.22 | 3.23 ± 0.34 | 3.48 ± 0.27 |
C2GCO3 | 3.90 ± 0.32 | 1.56 ± 0.22 | 4.69 ± 0.51 |
C4Dd2 | 2.37 ± 0.17 | 2.55 ± 0.44 | 3.61 ± 0.32 |
Rate Constants (sec −1 × 10−3) |
|||
Glucose* VPL^ |
+ − |
−# − |
+ + |
HB3 | 8.03 ± 0.63 | 4.43 ± 0.25 | 9.85 ± 0.61 |
Dd2 | 5.29 ± 0.53 | 4.63 ± 0.39 | 7.21 ± 0.76 |
C2GCO3 | 7.05 ± 0.33 | 3.42 ± 0.37 | 9.43 ± 0.65 |
C4Dd2 | 4.24 ± 0.32 | 3.91 ± 0.30 | 8.51 ± 0.83 |
5mM D-Glucose
No glucose substitution
1µM Verapamil
Using external 250 nM NBD-CQ, influx kinetics were measured in the presence (2nd column), vs absence of glucose (3rd column) and with a constant external concentration of 1 µM Verapamil (4th column) for several parasite lines; CQS parasites HB3 and C2GCO3, and CQR parasites Dd2 and C4Dd2. Similar patterns were also measured at 100 and 500 nM NBD-CQ in the perfusate (data not shown).